This Point-of-Care Diagnostics Devices and Equipment market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The point-of-care diagnostics devices and equipment market size has grown rapidly in recent years. It will grow from $61.43 billion in 2024 to $69.96 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to infectious disease outbreaks, patient convenience, remote and resource-limited areas, preventive care.
The point-of-care diagnostics devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $111.87 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to healthcare accessibility, global health threats, chronic disease management, telehealth and remote monitoring. Major trends in the forecast period include multiplex testing, smartphone integration, personalized medicine, lab-on-a-chip technology.
Several significant trends are expected to shape the upcoming period, including the development of multiplex testing, enabling the simultaneous detection of multiple analytes in a single test, thereby enhancing diagnostic capabilities. Another trend is smartphone integration, allowing users to connect their diagnostic devices to mobile apps for data management and reporting. The growing adoption of personalized medicine and the emergence of lab-on-a-chip technology are also expected to improve the capabilities of point-of-care diagnostic devices and contribute to their continued growth.
The increase in the incidence of target diseases is driving the growth of the Point-of-Care (POC) devices and equipment market globally. The rising prevalence of chronic diseases, such as diabetes, rheumatism, and cancer, is steadily increasing due to poor lifestyle choices and the growing rates of obesity. This trend is contributing to the expansion of the POC market. For instance, in March 2022, the IDF Diabetes Atlas, a Belgium-based global resource offering insights on diabetes prevalence, treatment, and care, projected that the global prevalence of diabetes would rise from 643 million cases in 2030 to 783 million by 2045, adding 140 million new cases. Currently, 537 million adults live with diabetes, with over 75% of them residing in low- and middle-income countries.
The increasing adoption of mobile health technologies is set to propel the growth of the point-of-care diagnostics devices market. Mobile health, which involves the use of mobile devices such as smartphones, tablets, and wearable technology for healthcare services and health data monitoring, relies on point-of-care diagnostics (POC) devices to enable rapid and convenient testing and data collection at or near the patient's location. These devices offer immediate results for various medical tests and are often integrated with mobile apps or connected to smartphones for data management and transmission. For instance, a 2022 survey by Rock Health indicated an 8-percentage point increase, with 80% of respondents reporting the use of telemedicine for healthcare at some point in their lives, showcasing the growing adoption of mobile health technologies.
Over-the-counter (OTC) testing is considered a significant trend driving the growth of the point-of-care diagnostics market. FDA-approved OTC test kits for cholesterol, fecal occult blood, pregnancy, and HIV/HCV have the potential to enhance access to testing and early disease detection. These testing kits may generate more revenue than prescription tests over the forecast period due to their ease of use, increased home care and self-testing, and a rising availability and adoption rate.
Major companies in the point-of-care diagnostic devices and equipment market are developing innovative products such as Cippoint to improve access to healthcare and reduce diagnosis time. Cippoint is a state-of-the-art point-of-care testing device for multiple health conditions, offering a wide range of testing parameters, including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. For instance, in January 2023, Cipla Limited launched Cippoint, an immunofluorescence-based quantitative analyzer that provides rapid test results, enabling healthcare professionals to make clinical decisions more quickly and efficiently in various settings.
Point-of-care diagnostics devices are essential tools designed to assist healthcare professionals in conducting immediate medical diagnostic tests at or in close proximity to the patient's location. These devices are instrumental in providing rapid and on-the-spot information regarding various diseases or health conditions. They find application in a wide range of diagnostic tests, such as measuring glucose and cholesterol levels, electrolyte and enzyme analysis, detecting drugs of abuse, and diagnosing infectious diseases and pregnancy.
The primary categories of point-of-care diagnostic devices and equipment include infectious disease testing kits, cardiometabolic monitoring kits, cholesterol testing kits, pregnancy and fertility test kits, tumor/cancer markers, urinalysis testing kits, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, and various other diagnostic tools. Pregnancy and fertility test kits, for example, are point-of-care diagnostic devices that enable individuals to assess pregnancy and fertility status without the need to visit a healthcare provider. These devices are available in various prescription modes, including prescription-based testing devices and over-the-counter (OTC) testing devices. They serve a diverse range of end-users, including professional diagnostic centers, hospitals and critical care facilities, outpatient healthcare settings, ambulatory care facilities, research laboratories, and homes, contributing to more accessible and immediate healthcare information.
The point-of-care diagnostics devices and equipment market research report is one of a series of new reports that provides point-of-care diagnostics devices and equipment market statistics, including point-of-care diagnostics devices and equipment industry global market size, regional shares, competitors with a point-of-care diagnostics devices and equipment market share, detailed point-of-care diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care diagnostics devices and equipment industry. This point-of-care diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major companies operating in the point-of-care diagnostics devices and equipment market include Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Danaher, Beckman Coulter, Becton Dickinson and Company, Qiagen N.V., Johnson & Johnson, Alere, BioMerieux, Chembio Diagnostic Systems, Quidel Corporation, EKF Diagnostics, Trinity Biotech Plc, OraSure Technologies, Sysmex Corporation, Radiometer Medical ApS, Response Biomedical Corporation, Bio-Rad Laboratories, Illumina, Thermo Fisher Scientific Inc., LabCorp, Luminex Corporation, LifeScan, Nova, Sekisui Diagnostics, Hemocue AB, Akers Biosciences, 3D Systems Healthcare, Artec 3D, Canon Medical Systems Corporation, Carestream Health, ContextVision, CurveBeam, EchoPixel, EOS Imaging, Esaote, GE Healthcare, Hitachi Healthcare, Hologic, Intrasense, KaVo Kerr, Konica Minolta Healthcare, Materialise, Mobius Imaging, Neusoft Medical Systems, Orfit Industries, Philips Healthcare, Pie Medical Imaging, Planmed Oy, Sectra, Shenzhen Mindray Bio-Medical Electronics, Shimadzu Corporation, Varian Medical Systems, Ziehm Imaging GmbH.
North America was the largest region in the point-of-care diagnostic devices and equipment market in 2024. Asia-Pacific was the second-largest region in the global point-of-care diagnostics devices and equipment market. The regions covered in the point-of-care diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the point-of-care diagnostics devices and equipment market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The point-of-care diagnostics market consists of sales of instruments such as pregnancy and fertility testing kits, cholesterol test strips, drug abuse testing kits, and others that are used in point-of-care diagnostics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The point-of-care diagnostics devices and equipment market size has grown rapidly in recent years. It will grow from $61.43 billion in 2024 to $69.96 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to infectious disease outbreaks, patient convenience, remote and resource-limited areas, preventive care.
The point-of-care diagnostics devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $111.87 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to healthcare accessibility, global health threats, chronic disease management, telehealth and remote monitoring. Major trends in the forecast period include multiplex testing, smartphone integration, personalized medicine, lab-on-a-chip technology.
Several significant trends are expected to shape the upcoming period, including the development of multiplex testing, enabling the simultaneous detection of multiple analytes in a single test, thereby enhancing diagnostic capabilities. Another trend is smartphone integration, allowing users to connect their diagnostic devices to mobile apps for data management and reporting. The growing adoption of personalized medicine and the emergence of lab-on-a-chip technology are also expected to improve the capabilities of point-of-care diagnostic devices and contribute to their continued growth.
The increase in the incidence of target diseases is driving the growth of the Point-of-Care (POC) devices and equipment market globally. The rising prevalence of chronic diseases, such as diabetes, rheumatism, and cancer, is steadily increasing due to poor lifestyle choices and the growing rates of obesity. This trend is contributing to the expansion of the POC market. For instance, in March 2022, the IDF Diabetes Atlas, a Belgium-based global resource offering insights on diabetes prevalence, treatment, and care, projected that the global prevalence of diabetes would rise from 643 million cases in 2030 to 783 million by 2045, adding 140 million new cases. Currently, 537 million adults live with diabetes, with over 75% of them residing in low- and middle-income countries.
The increasing adoption of mobile health technologies is set to propel the growth of the point-of-care diagnostics devices market. Mobile health, which involves the use of mobile devices such as smartphones, tablets, and wearable technology for healthcare services and health data monitoring, relies on point-of-care diagnostics (POC) devices to enable rapid and convenient testing and data collection at or near the patient's location. These devices offer immediate results for various medical tests and are often integrated with mobile apps or connected to smartphones for data management and transmission. For instance, a 2022 survey by Rock Health indicated an 8-percentage point increase, with 80% of respondents reporting the use of telemedicine for healthcare at some point in their lives, showcasing the growing adoption of mobile health technologies.
Over-the-counter (OTC) testing is considered a significant trend driving the growth of the point-of-care diagnostics market. FDA-approved OTC test kits for cholesterol, fecal occult blood, pregnancy, and HIV/HCV have the potential to enhance access to testing and early disease detection. These testing kits may generate more revenue than prescription tests over the forecast period due to their ease of use, increased home care and self-testing, and a rising availability and adoption rate.
Major companies in the point-of-care diagnostic devices and equipment market are developing innovative products such as Cippoint to improve access to healthcare and reduce diagnosis time. Cippoint is a state-of-the-art point-of-care testing device for multiple health conditions, offering a wide range of testing parameters, including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. For instance, in January 2023, Cipla Limited launched Cippoint, an immunofluorescence-based quantitative analyzer that provides rapid test results, enabling healthcare professionals to make clinical decisions more quickly and efficiently in various settings.
Point-of-care diagnostics devices are essential tools designed to assist healthcare professionals in conducting immediate medical diagnostic tests at or in close proximity to the patient's location. These devices are instrumental in providing rapid and on-the-spot information regarding various diseases or health conditions. They find application in a wide range of diagnostic tests, such as measuring glucose and cholesterol levels, electrolyte and enzyme analysis, detecting drugs of abuse, and diagnosing infectious diseases and pregnancy.
The primary categories of point-of-care diagnostic devices and equipment include infectious disease testing kits, cardiometabolic monitoring kits, cholesterol testing kits, pregnancy and fertility test kits, tumor/cancer markers, urinalysis testing kits, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, and various other diagnostic tools. Pregnancy and fertility test kits, for example, are point-of-care diagnostic devices that enable individuals to assess pregnancy and fertility status without the need to visit a healthcare provider. These devices are available in various prescription modes, including prescription-based testing devices and over-the-counter (OTC) testing devices. They serve a diverse range of end-users, including professional diagnostic centers, hospitals and critical care facilities, outpatient healthcare settings, ambulatory care facilities, research laboratories, and homes, contributing to more accessible and immediate healthcare information.
The point-of-care diagnostics devices and equipment market research report is one of a series of new reports that provides point-of-care diagnostics devices and equipment market statistics, including point-of-care diagnostics devices and equipment industry global market size, regional shares, competitors with a point-of-care diagnostics devices and equipment market share, detailed point-of-care diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care diagnostics devices and equipment industry. This point-of-care diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major companies operating in the point-of-care diagnostics devices and equipment market include Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Danaher, Beckman Coulter, Becton Dickinson and Company, Qiagen N.V., Johnson & Johnson, Alere, BioMerieux, Chembio Diagnostic Systems, Quidel Corporation, EKF Diagnostics, Trinity Biotech Plc, OraSure Technologies, Sysmex Corporation, Radiometer Medical ApS, Response Biomedical Corporation, Bio-Rad Laboratories, Illumina, Thermo Fisher Scientific Inc., LabCorp, Luminex Corporation, LifeScan, Nova, Sekisui Diagnostics, Hemocue AB, Akers Biosciences, 3D Systems Healthcare, Artec 3D, Canon Medical Systems Corporation, Carestream Health, ContextVision, CurveBeam, EchoPixel, EOS Imaging, Esaote, GE Healthcare, Hitachi Healthcare, Hologic, Intrasense, KaVo Kerr, Konica Minolta Healthcare, Materialise, Mobius Imaging, Neusoft Medical Systems, Orfit Industries, Philips Healthcare, Pie Medical Imaging, Planmed Oy, Sectra, Shenzhen Mindray Bio-Medical Electronics, Shimadzu Corporation, Varian Medical Systems, Ziehm Imaging GmbH.
North America was the largest region in the point-of-care diagnostic devices and equipment market in 2024. Asia-Pacific was the second-largest region in the global point-of-care diagnostics devices and equipment market. The regions covered in the point-of-care diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the point-of-care diagnostics devices and equipment market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The point-of-care diagnostics market consists of sales of instruments such as pregnancy and fertility testing kits, cholesterol test strips, drug abuse testing kits, and others that are used in point-of-care diagnostics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Executive Summary
Point-of-Care Diagnostics Devices and Equipment Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on point-of-care diagnostics devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for point-of-care diagnostics devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point-of-care diagnostics devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Infectious disease testing kits; Cardio metabolic monitoring kits; Cholesterol testing kits; Pregnancy and fertility tests kits; Tumor or cancer markers; Urinalysis testing kits; Hematology testing kits; Drugs of abuse testing kits; Fecal occult testing kits; Other Types2) By Prescription Mode: Prescription-based Testing Devices; Over-the-Counter (OTC) Testing Devices
3) By End User: Professional diagnostic centers; Hospitals/critical care centers; Outpatient healthcare Setting; Ambulatory care settings; Research laboratories; Home
Subsegments:
1) By Infectious Disease Testing Kits: HIV Testing Kits; Hepatitis Testing Kits; Malaria Testing Kits; Influenza Testing Kits; COVID-19 Testing Kits; Other Infectious Disease Testing Kits2) By Cardio Metabolic Monitoring Kits: Blood Glucose Testing Kits; Blood Pressure Monitoring Kits; Lipid Testing Kits; Other Cardio Metabolic Monitoring Kits
3) By Cholesterol Testing Kits: Total Cholesterol Testing Kits; HDL Cholesterol Testing Kits; LDL Cholesterol Testing Kits; Triglyceride Testing Kits
4) By Pregnancy and Fertility Test Kits: Pregnancy Test Kits; Ovulation Test Kits; Fertility Monitoring Kits
5) By Tumor or Cancer Markers: Prostate-Specific Antigen (PSA) Test Kits; Human Epidermal Growth Factor Receptor 2 (HER2) Test Kits; CA-125 Test Kits; Alpha-Fetoprotein (AFP) Test Kits; Other Cancer Marker Test Kits
6) By Urinalysis Testing Kits: Protein Testing Kits; Glucose Testing Kits; pH Testing Kits; Specific Gravity Testing Kits; Nitrite Testing Kits; Other Urinalysis Testing Kits
7) By Hematology Testing Kits: Complete Blood Count (CBC) Kits; Hemoglobin Testing Kits; Hematocrit Testing Kits; Platelet Count Kits; Other Hematology Testing Kits
8) By Drugs of Abuse Testing Kits: Marijuana Testing Kits; Cocaine Testing Kits; Opioid Testing Kits; Amphetamine Testing Kits; Other Drugs of Abuse Testing Kits
9) By Fecal Occult Testing Kits: Stool Blood Test Kits; Occult Blood Screening Kits; Other Fecal Occult Testing Kits
10) By Other Types: Glucose Monitoring Kits; Temperature Monitoring Kits; Oxygen Saturation Monitoring Kits; Other Specialty Point-of-Care Kits.
Key Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche AG; Siemens Healthineers; Danaher; Beckman Coulter
Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Point-of-Care Diagnostics Devices and Equipment market report include:- Abbott Laboratories
- F. Hoffmann-La Roche AG
- Siemens Healthineers
- Danaher
- Beckman Coulter
- Becton Dickinson and Company
- Qiagen N.V.
- Johnson & Johnson
- Alere
- BioMerieux
- Chembio Diagnostic Systems
- Quidel Corporation
- EKF Diagnostics
- Trinity Biotech Plc
- OraSure Technologies
- Sysmex Corporation
- Radiometer Medical ApS
- Response Biomedical Corporation
- Bio-Rad Laboratories
- Illumina
- Thermo Fisher Scientific Inc.
- LabCorp
- Luminex Corporation
- LifeScan
- Nova
- Sekisui Diagnostics
- Hemocue AB
- Akers Biosciences
- 3D Systems Healthcare
- Artec 3D
- Canon Medical Systems Corporation
- Carestream Health
- ContextVision
- CurveBeam
- EchoPixel
- EOS Imaging
- Esaote
- GE Healthcare
- Hitachi Healthcare
- Hologic
- Intrasense
- KaVo Kerr
- Konica Minolta Healthcare
- Materialise
- Mobius Imaging
- Neusoft Medical Systems
- Orfit Industries
- Philips Healthcare
- Pie Medical Imaging
- Planmed Oy
- Sectra
- Shenzhen Mindray Bio-Medical Electronics
- Shimadzu Corporation
- Varian Medical Systems
- Ziehm Imaging GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | April 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 69.96 Billion |
| Forecasted Market Value ( USD | $ 111.87 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 55 |
